Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Recombinant BCG tuberculosis vaccine designed to elicit immune responses to Mycobacterium tuberculosis in all physiological stages of infection and disease

Recombinant BCG tuberculosis vaccine designed to elicit immune responses to Mycobacterium tuberculosis in all physiological stages of infection and disease

US Patent 7670609 · Granted Mar 2, 2010

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Compositions and methods for preventing and treating coronavirus infection—SARS-2022
Compositions and methods for preventing and treating coronavirus infection—SARS-2022
Methods and compositions for inducing protective immunity against RSV infection2022
Method for the safe induction of immunity against RSV2022
Recombinant mycobacterium encoding a heparin-binding hemagglutinin (HBHA) fusion2018
Bacillus anthracis HtrA-defective-derived vaccines2017
Uniformly conjugated serine hydrolases2015
Therapeutic vaccination against active Tuberculosis2014
Malaria vaccine compositions and constituents which elicit cell mediated immunit2014
Malaria vaccine compositions and constituents which elicit cell mediated immunit2014
Malaria vaccine compositions and constituents which elicit cell mediated immunit2014
Malaria vaccine compositions and constituents which elicit cell mediated immunit2014